COVID-19 leviku tõkestamiseks avatud taotlusvoorud valdkondade kaupa

7. mai, 2020

Info täieneb jooksvalt

KAITSEVALDKOND

Taotlusvooru lõpp Nimi Ülevaade
28.mai.20 Open call for innovation – emerging innovations This encourages proposals across a wide range of technology areas with the aim of finding new and novel opportunities for these to be exploited across defence or security.
28.mai.20 Peer reviewed medical research programme – technology and therapeutic development award for emerging viral diseases and respiratory health This supports the translation of promising preclinical findings into products for clinical applications in emerging viral diseases and respiratory health. Products in development should be responsive to the healthcare needs of military service members veterans or beneficiaries.

 

KLIIMA

Taotlusvooru lõpp Nimi Ülevaade
31.juuli.20 Call for code global challenge This recognises practical and sustainable open source solutions to mitigate the impact of COVID-19 and climate change. Five prizes are available, worth between USD 10,000 and USD 200,000.
06.okt.20 LIFE – integrated projects This call supports the implementation of large territorial scale environmental and climate plans or strategies within the EU. Grants are worth on average €10 million at up to 60 per cent co-funding of eligible costs.

 

KOSMOS

Taotlusvooru lõpp Nimi Ülevaade
15.mai.20 COVID-19 related proposal This supports projects and partnerships that in some way use astronomy, in any of its aspects, to help mitigate some of the negative effects of the pandemic.

 

RAHVATERVIS JA HUMANITAARABI

Taotlusvooru lõpp Nimi Ülevaade
15.mai.20 Pipeline accelerator COVID-19 rapid response This call focus solely on projects related to COVID-19, including any aspect of the national or global response, such as high throughput screening, assay development, drug repurposing, diagnostic development, pre-clinical and clinical trial support, analytical validation, pilot scale production.
18.mai.20 Research projects to help improve the understanding and management of COVID-19 in people living with HIV This supports basic and clinical research studies within specific areas of interest, with the goal of improving understanding and management of the COVID-19 pandemic in people living with HIV.
22.mai.20 Supporting engagement in and dissemination of PCOR/CER in the context of COVID-19 This enables organisations with strong ties to patients, caregivers, clinicians and other stakeholders to equip them to engage as partners in patient-centred outcomes research and clinical effectiveness research in the context of the COVID-19 pandemic.
26.mai.20 COVID-19 targeted funding announcement The aims are to strengthen the understanding of different approaches to mitigate the impact of COVID-19 on individuals, communities, healthcare providers and healthcare systems and to provide evidence to inform clinical and public health responses, decision making and planning.
27.mai.20 EIT Health – proposals addressing the management and response to pandemics These grants support research into the prevention and management of the COVID-19 pandemic as well as potential future pandemics.
28.mai.20 Peer reviewed medical research programme – investigator-initiated research award for emerging viral diseases and respiratory health This supports studies that will make an important contribution toward research or patient care in the areas of emerging viral diseases and respiratory health.
30.mai.20 COVID-19 and emerging respiratory viruses research award This supports research focusing on emerging respiratory pathogens like SARS-CoV-2. Projects must directly be related to COVID-19 or other viral respiratory threats that may arise in the future.
5.juuni.20 COVID-19 research grant This supports research that will provide high-impact new knowledge to advance emergency patient care, improve response of hospitals, healthcare and emergency medical services systems, and protect emergency medicine healthcare professionals during pandemics.
18.juuni.20 Health security and pandemics challenge This supports innovative, human-centred, technology-based solutions to the coronavirus disease 2019 pandemic. Grants are worth USD 10,000.
19.juuni.20 Notice of special interest – emergency competitive revisions for research on severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 This supports research focusing on prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. The aim is to rapidly improve the understanding, diagnosis and treatment of COVID-19.
10.nov.20 Notice of special interest – emergency competitive revisions and administrative supplements to clinical and translational science award programme awards to address 2019 novel coronavirus disease (COVID-19) public health needs This supports projects in translational science that address the COVID-19 public health emergency. Funding will be awarded to current clinical and translational science UL1 and U24 award holders.
01.mai.21 Notice of special interest – administrative supplements and revision supplements on coronavirus disease 2019 The aim is to improve understanding and available control measures for COVID-19 and to to improve prevention of disease transmission among older adults and mitigation of disease severity and mortality in older adults with the disease.
Jooksvalt COVID-19 rapid response rolling call This supports COVID-19 urgent public health research to gather the necessary clinical and epidemiological evidence that will inform national policy and enable new diagnostic tests, treatments and vaccines to be developed and tested for COVID-19. The size of grants varies according to the needs of each research project.
Jooksvalt Open call for research and innovation ideas to address COVID-19 This supports short-term projects addressing and mitigating the health, social, economic and environmental impacts of the COVID-19 outbreak. Projects last between 12 to 18 months and funding covers 80 per cent of full economic costs.
Jooksvalt Funding for research into humanitarian crises like epidemics and pandemics This supports projects for research into humanitarian crises such as epidemics and pandemics.
Jooksvalt PRACE support to mitigate the impact of COVID-19 pandemic This enables researchers to access computing resources to contribute to the mitigation of the impact of the COVID-19 pandemic. Access will be awarded for between three and six months and sized from 30 to 50 million core hours.

 

SOTSIAAL- JA HUMANITAARTEADUSED

Taotlusvooru lõpp Nimi Ülevaade
11.mai.20 Research grants on women, victimisation and COVID-19 This supports research on women, victimisation and domestic violence, with a particular emphasis on the impact of the current COVID-19 pandemic.
19.mai.20 Study on the implications of COVID-19 for women victims of intimate partner violence The European Institute for Gender Equality invites tenders for a study on the implications of COVID-19 for women victims of intimate partner violence.
1.juuni.20 Rapid-response grants on COVID-19 and the social sciences These support innovative research projects that deploy remote research methods to shed light on both the short- and potential long-term effects of COVID-19 across a range of issues.
16.juuni.20 Social data research and dissertation fellowships These aim to encourage multifaceted pathways for the collection and analysis of social data, with the larger aim of cultivating research on technology and society. Applications investigating the impact of the coronavirus are particularly encouraged.
26.juuni.20 Applying history to clarify the COVID-19 challenge prizes These recognise academic articles that address the coronavirus crisis from a historical perspective. Articles should analyse history to clarify the medical, political, economic or international impact of coronavirus, and identify lessons or clues for policymakers.
31.okt.20 Urgency grants pilot This enables arts and humanities researchers to respond in an agile way to unanticipated urgent research needs and opportunities that meet a development need or challenge, or have the potential to support LMICs to address the UN sustainable development goals. Proposals may have eligible costs of up to £150,000 for up to one year and are funded at 80 per cent of full economic costs.
31.märts.21 Notice of special interest – administrative supplements and urgent competitive revisions for research on the 2019 novel coronavirus and the behavioural and social sciences This supports longitudinal studies that address key social and behavioural questions related to the COVID-19 pandemic. The aim is to improve our understanding of the critical social and behavioural aspects of the COVID-19 pandemic.

 

VIIRUSE UURINGUD

Taotlusvooru lõpp Nimi Ülevaade
15.mai.20 Notice of special interest – urgent competitive revisions for research on the 2019 novel coronavirus This supports research focusing on understanding the host response, associated disease and short- and long-term clinical outcomes of individuals infected with SARS-CoV-2. Grants are worth up to USD 250,000 for up to one year.
15.mai.20 Pipeline accelerator COVID-19 rapid response This call focus solely on projects related to COVID-19, including any aspect of the national or global response, such as high throughput screening, assay development, drug repurposing, diagnostic development, pre-clinical and clinical trial support, analytical validation, pilot scale production.
18.mai.20 Research projects to help improve the understanding and management of COVID-19 in people living with HIV This supports basic and clinical research studies within specific areas of interest, with the goal of improving understanding and management of the COVID-19 pandemic in people living with HIV.
28.mai.20 Peer reviewed medical research programme – investigator-initiated research award for emerging viral diseases and respiratory health This supports studies that will make an important contribution toward research or patient care in the areas of emerging viral diseases and respiratory health.
30.mai.20 COVID-19 and emerging respiratory viruses research award This supports research focusing on emerging respiratory pathogens like SARS-CoV-2. Projects must directly be related to COVID-19 or other viral respiratory threats that may arise in the future.
19.juuni.20 Notice of special interest – emergency competitive revisions for research on severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 This supports research focusing on prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. The aim is to rapidly improve the understanding, diagnosis and treatment of COVID-19.
31.juuli.20 Biomedical Advanced Research and Development Authority broad agency announcement This supports advanced research and development of medical countermeasures for chemical, biological, radiological and nuclear (CBRN) agents, pandemic influenza, and emerging infectious diseases that threaten the US civilian population, with a particular focus on COVID-19.
2.nov.20 Notice of special interest – clinical and translational science award programme applications to address 2019 novel coronavirus public health need This supports research on the 2019 novel coronavirus (COVID-19), with a particular focus on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources to advance the translation of research findings into diagnostics, therapeutics and vaccines.
05.veebr.21 Notice of special interest – urgent competitive revisions for research on coronavirus disease 2019 (COVID-19) and the causative virus SARS-CoV-2 This supports research aimed at better understanding SARS-CoV-2, improving the predictive quality of existing models of spread, diagnostics for measurement of transmission, susceptibility and recovery and development of therapeutic interventions.
25.märts.21 Notice of special interest – availability of emergency competitive revisions for research on severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 This supports research on SARS-CoV-2 and COVID-19 with a particular focus on viral natural history, pathogenicity and transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics.
Jooksvalt COVID-19 rapid response rolling call This supports COVID-19 urgent public health research to gather the necessary clinical and epidemiological evidence that will inform national policy and enable new diagnostic tests, treatments and vaccines to be developed and tested for COVID-19. The size of grants varies according to the needs of each research project.
Jooksvalt Deuteration and macromolecular crystallisation platform access for COVID-19 research This enables scientists and researchers working on COVID-19-related research projects to access laboratory services through the deuteration and macromolecular crystallisation platform (DEMAX) at ESS.
Jooksvalt Open call for research and innovation ideas to address COVID-19 This supports short-term projects addressing and mitigating the health, social, economic and environmental impacts of the COVID-19 outbreak. Projects last between 12 to 18 months and funding covers 80 per cent of full economic costs.
Jooksvalt Funding for research into humanitarian crises like epidemics and pandemics This supports projects for research into humanitarian crises such as epidemics and pandemics.
Jooksvalt PRACE support to mitigate the impact of COVID-19 pandemic This enables researchers to access computing resources to contribute to the mitigation of the impact of the COVID-19 pandemic. Access will be awarded for between three and six months and sized from 30 to 50 million core hours.

 

MUU

Taotlusvooru lõpp Nimi Ülevaade
13.mai.20 Wearable diagnostic for detection of COVID-19 infection This supports research focusing on the development of a wearable diagnostic capability for the pre- and very early symptomatic detection of COVID-19 infection.
14.mai.20 COVID-19 rapid collaboration call This aims to enable quicker open science by supporting institutions in harmonising COVID-19 clinical data to the observational medical outcomes partnership common data model.
21.mai.20 New technologies to prevent the transmission of coronavirus This seeks new mask designs and technologies as well as new ideas for personal protective equipment to prevent the transmission of respiratory viruses such as coronavirus.
24.mai.20 What should we know to better treat coronavirus This seeks well-defined problems aimed at advancing the knowledge about coronavirus and how to respond more effectively against it. The total budget is worth at least USD 500.
27.mai.20 EIT Health – proposals addressing the management and response to pandemics These grants support research into the prevention and management of the COVID-19 pandemic as well as potential future pandemics.
1.juuni.20 Notice of special interest – administrative supplements for research on coronavirus disease 2019 The aim is to improve our understanding of SARS-CoV-2 and COVID-19. Research is expected to focus on informatics and data science methods to help address the COVID-19 pandemic.
1.juuni.20 STOP spillover This aims to use an evidence-based approach to develop, deploy and evaluate interventions to reduce the spillover of emerging zoonotic viruses at high-risk animal-human interfaces, and reduce amplification and spread of these threats at high-risk foci such as health care facilities.
1.juuni.20 Notice of special interest – urgent competitive revision and administrative for coronavirus disease 2019 research within the mission of the NIDCR This supports research with immediate and high impact to protect and ensure the safety of personnel and patients in dental practices.
5.juuni.20 Open call for experiments – COVID 19 This supports projects that directly contribute to reducing the spread of COVID-19 and other viruses through flexible wearable electronics as solutions in, among others, the field of prevention, diagnostics and therapy.
15.juuni.20 Anti-COVID-19 infection protective film This seeks ideas for a thin film that, when applied to hands and other open parts of the human body, would prevent people from being infected with COVID-19.
15.juuni.20 Artificial intelligence for health – COVID-19 grant The Microsoft Corporation invites proposals for its artificial intelligence for health COVID-19 grant. This supports research with potential benefits and a defined impact to the COVID-19 response.
16.juuni.20 Notice of special interest – data driven research on coronavirus disease 2019 This supports research to improve understanding of the infection of severe acute respiratory syndrome coronavirus (SARS-CoV-2) and coronavirus disease 2019 (COVID-19).
26.juuni.20 New investigator awards – COVID-19 These are intended to be pump-priming grants in the field of COVID-19 that will lead to further and more substantial support from other grant giving bodies. Projects must be focused on COVID-19 treatment and scientific discovery.
5.aug.20 Call for access This supports and accelerates vaccine-related projects in the preclinical phase of development, by providing access to the services and expertise contained within the Transvac infrastructure. COVID-19 vaccine development projects are encouraged to apply.
1.okt.20 Call for solution ideas to COVID-19 challenges AdditiveManufacturABLE (AMable) invites applications for its call for solution ideas to COVID-19 challenges. This supports additive manufacturing projects that may contribute to solving practical challenges in managing the COVID-19 pandemic.
5.okt.20 Notice of special interest – emergency competitive revisions on coronavirus disease 2019 for currently active NHLBI phase I-III clinical trials This supports research focusing on the safety and efficacy of interventions for primary prevention or treatment of COVID-19, associated clinical phenotypes and surrogate outcomes relevant to heart, lung and blood diseases.
2.nov.20 Notice of special interest – clinical and translational science award programme applications to address 2019 novel coronavirus public health need This supports research on the 2019 novel coronavirus (COVID-19), with a particular focus on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources to advance the translation of research findings into diagnostics, therapeutics and vaccines.
31.märts.21 Notice of special interest – administrative supplements and urgent competitive revisions for research on the 2019 novel coronavirus These provide revision funding to active grants to address research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.
31.märts.21 Notice of special interest – administrative supplements and urgent competitive revisions for research on the 2019 novel coronavirus and the behavioural and social sciences This supports longitudinal studies that address key social and behavioural questions related to the COVID-19 pandemic. The aim is to improve our understanding of the critical social and behavioural aspects of the COVID-19 pandemic.

Kommenteerimine on suletud